Early-stage funding Revibe Technologies is in a seed to early funding phase with $250K invested by The Launch Place and Carolina Angel Network, suggesting a need for partnerships that can help scale regulatory-ready digital therapies and wearables.

Clinical development The company has appointed a Chief Scientific Officer to drive clinical and regulatory development of a digital wearable therapeutic, indicating opportunities to collaborate on clinical validation, trials, and regulatory strategy.

ADHD autism focus Product targets attention-related disorders in both children and adults using a wearable with proprietary algorithms for distraction management, presenting sales opportunities with schools, clinics, pediatric and neurodevelopmental programs.

Pilot market entry Very small headcount (2-10 employees) implies lean operations; potential for partnerships with health tech integrators, educational tech distributors, or contract research organizations to accelerate go‑to‑market and deployment.

Industry alignment Industry peers and competitors include medical device and neurotech players; opportunities exist to position Revibe as a digital therapeutic companion, enabling collaborations with schools, therapy centers, and family-centered care programs.